![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bames RB, Ehrmann DA. 1997. Long-term suppression of testosterone after treatment with gonadotropin releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumour. Journal of Clinical Endocrinology and Metabolism 82:1746–1748.
- De Freitas EA, Dudzinski MR, LaRocque JC, et al 1991. Ovarian vein sampling in rapidly progressing virilization: a case report. Journal of Reproductive Medicine 36:546–548.
- Hayes MC, Scully RE. 1987. Ovarian steroid cell tumor not otherwise specified: a clinicopathological analysis of 63 cases. American Journal of Surgical Pathology 11:835–845.
- Homesely HD, Bundy BN, Hureau JA, et al 1998. Bleomycin, etoposide and cisplatin (BEP) as first line therapy of ovarian stromal malignancies. Gynaecological Oncology 68:116.
- Jung SE, Rha SE, Lee JM, et al 2005. CT and MRI findings of sex cord-stromal tumour of the ovary. American Journal of Roentgenology 185:207–215.
- Reedy MB, Richards WE, Ueland F, et al 1999. Ovarian steroid cell tumors, not otherwise specified: a case report and literature review. Gynaecologic Oncology 75:293–297.
- Young RH, Path FRC, Scully RE. 1994. Sex cord-stromal, steroid cell, and other ovarian tumors with endocrine, paraendocrine and paraneoplastic manifestations. In: Blaunstein's pathology of the female genital tract. Kurman RJ, editor. New York: Springer-Verlag. pp 783–847.